Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.63
0.010.38%
At close: Dec 4, 4:00 PM EST
$2.75
0.124.45%
After Hours: 5:53 PM EST
Comments
Loading...
OnKure Therapeutics Analyst Ratings and Price Targets | NASDAQ:OKUR | Benzinga
OnKure Therapeutics Inc has a consensus price target of $32.25 based on the ratings of 4 analysts. The high is $34 issued by HC Wainwright & Co. on August 26, 2025. The low is $30 issued by Oppenheimer on March 11, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Oppenheimer on August 26, 2025, March 18, 2025, and March 11, 2025, respectively. With an average price target of $32.67 between HC Wainwright & Co., HC Wainwright & Co., and Oppenheimer, there's an implied 1089.18% upside for OnKure Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Oppenheimer
Jones Trading
Leerink Partners
1calculated from analyst ratings
Analyst Ratings for OnKure Therapeutics
Get Alert | |||||
|---|---|---|---|---|---|
Aug 26, 2025 | 1137.71% | Previous Buy Current Buy | |||
Mar 18, 2025 | 1137.71% | Previous Buy Current Buy | |||
Mar 11, 2025 | 992.1% | Previous Outperform Current Outperform | |||
Jan 28, 2025 | 1064.91% | Previous Initiates Current Buy | |||
Dec 5, 2024 | 1101.31% | Previous Initiates Current Outperform | |||
Nov 8, 2024 | 1356.13% | Previous Buy Current Buy | |||
Oct 17, 2024 | 1356.13% | Previous Current Buy | |||
Oct 10, 2024 | 1174.12% | Previous Initiates Current Outperform |
FAQ
What is the target price for OnKure Therapeutics (OKUR) stock?
The latest price target for OnKure Therapeutics (NASDAQ:OKUR) was reported by HC Wainwright & Co. on August 26, 2025. The analyst firm set a price target for $34.00 expecting OKUR to rise to within 12 months (a possible 1137.71% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for OnKure Therapeutics (OKUR)?
The latest analyst rating for OnKure Therapeutics (NASDAQ:OKUR) was provided by HC Wainwright & Co., and OnKure Therapeutics reiterated their buy rating.
When was the last upgrade for OnKure Therapeutics (OKUR)?
There is no last upgrade for OnKure Therapeutics
When was the last downgrade for OnKure Therapeutics (OKUR)?
There is no last downgrade for OnKure Therapeutics.
When is the next analyst rating going to be posted or updated for OnKure Therapeutics (OKUR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OnKure Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OnKure Therapeutics was filed on August 26, 2025 so you should expect the next rating to be made available sometime around August 26, 2026.
Is the Analyst Rating OnKure Therapeutics (OKUR) correct?
While ratings are subjective and will change, the latest OnKure Therapeutics (OKUR) rating was a reiterated with a price target of $34.00 to $34.00. The current price OnKure Therapeutics (OKUR) is trading at is $2.75, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
